High Levels of Antidrug Antibodies Against Atezolizumab as a Predictive Marker for Clinical Outcomes in Patients With Hepatocellular Carcinoma.
作者信息
Shigematsu Yasuyuki, Inamura Kentaro
机构信息
The Cancer Institute Hospital, Department of Pathology, Japanese Foundation for Cancer Research, Tokyo, Japan.
The Cancer Institute, Division of Pathology, Japanese Foundation for Cancer Research, Tokyo, Japan.
出版信息
JAMA Oncol. 2023 May 1;9(5):725. doi: 10.1001/jamaoncol.2023.0108.
PMID:36928513
Abstract
摘要
Zotero 插件